{{Rsnum
|rsid=568408
|Gene=IL12A
|Chromosome=3
|position=159995680
|Orientation=plus
|GMAF=0.1281
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=IL12A,IL12A-AS1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 23.9 | 73.5
| HCB | 0.8 | 22.9 | 76.3
| JPT | 1.8 | 26.4 | 71.8
| YRI | 5.6 | 31.9 | 62.5
| ASW | 7.0 | 29.8 | 63.2
| CHB | 0.8 | 22.9 | 76.3
| CHD | 0.9 | 23.9 | 75.2
| GIH | 13.1 | 42.4 | 44.4
| LWK | 6.5 | 38.3 | 55.1
| MEX | 0.0 | 25.0 | 75.0
| MKK | 1.9 | 30.3 | 67.7
| TSI | 1.0 | 17.3 | 81.6
| HapMapRevision=28
}}
{{PMID|19118071}} [[rs568408]](A) and [[rs3212227]](C) variant genotypes were associated with a significantly increased risk of [[cervical cancer]] [adjusted odds ratio, 1.43; 95% confidence interval (CI), 1.06-1.93; and adjusted odds ratio, 1.30; 95% CI, 0.97-1.75, respectively]. subjects carrying variant genotypes of both loci had a 1.82-fold (95% CI, 1.28-2.57) increased risk of cervical cancer

{{PMID Auto
|PMID=21513752
|Title=Association of single nucleotide polymorphisms in interleukin 12 (IL-12A and -B) with asthma in a Chinese population
}}

{{PMID Auto
|PMID=16449530
|Title=Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=17327408
|Title=Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
|OA=1
}}

{{PMID Auto
|PMID=18633131
|Title=Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
|OA=1
}}

{{PMID Auto
|PMID=19066394
|Title=Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=20521253
|Title=IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population.
}}

{{PMID Auto
|PMID=20544370
|Title=Association of genetic polymorphisms in the IL12-IFNG pathway with susceptibility to and prognosis of pulmonary tuberculosis in a Chinese population.
}}

{{PMID Auto
|PMID=20952689
|Title=Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=21044109
|Title=Association study of interleukin-12A gene polymorphisms with Graves' disease in two Chinese populations.
}}

{{PMID Auto
|PMID=22515181
|Title=Interleukin-12: clinical usage and molecular markers of cancer susceptibility.
}}

{{PMID Auto
|PMID=22614250
|Title=Contribution of IL12A and IL12B Polymorphisms to the Risk of Cervical Cancer.
}}

{{PMID Auto
|PMID=22740240
|Title=Associations between polymorphisms in IL-12A, IL-12B, IL-12Rbeta1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer.
}}

{{PMID Auto
|PMID=22940148
|Title=Functional polymorphisms in the interleukin-12 gene contribute to cancer risk: evidence from a meta-analysis of 18 case-control studies.
}}

{{PMID Auto
|PMID=23065210
|Title=Interactions of interleukin-12A and interleukin-12B polymorphisms on the risk of intracranial aneurysm.
}}

{{PMID Auto
|PMID=25037175
|Title=Association of IL-12A and IL-12B polymorphisms with Alzheimer's disease susceptibility in a Han Chinese population
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}